FY2024 EPS Estimates for Henry Schein Lowered by Analyst

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Stock analysts at Leerink Partnrs lowered their FY2024 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $4.74 per share for the year, down from their prior estimate of $4.81. The consensus estimate for Henry Schein's current full-year earnings is $4.78 per share. Leerink Partnrs also issued estimates for Henry Schein's Q4 2024 earnings at $1.19 EPS, Q1 2025 earnings at $1.19 EPS, Q2 2025 earnings at $1.24 EPS, Q3 2025 earnings at $1.25 EPS, Q4 2025 earnings at $1.32 EPS, FY2025 earnings at $5.00 EPS, FY2026 earnings at $5.57 EPS and FY2027 earnings at $6.19 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the firm earned $1.32 EPS. The company's revenue was up .4% compared to the same quarter last year.

Several other research firms also recently weighed in on HSIC. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective on the stock. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Barrington Research raised their price target on Henry Schein from $82.00 to $90.00 and gave the stock an "outperform" rating in a report on Thursday. Seven analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $80.10.

Henry Schein Stock Performance

Shares of HSIC stock traded up $0.23 during mid-day trading on Thursday, hitting $80.10. 1,220,523 shares of the stock were exchanged, compared to its average volume of 1,309,118. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a market capitalization of $9.99 billion, a price-to-earnings ratio of 32.96, a P/E/G ratio of 2.04 and a beta of 0.89. The stock's fifty day simple moving average is $73.19 and its two-hundred day simple moving average is $71.27.

Institutional Trading of Henry Schein

A number of institutional investors have recently bought and sold shares of the company. Figure 8 Investment Strategies LLC acquired a new position in shares of Henry Schein during the 4th quarter worth $538,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Henry Schein during the fourth quarter worth about $2,281,000. Quent Capital LLC lifted its holdings in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. Equitable Trust Co. acquired a new stake in shares of Henry Schein in the fourth quarter valued at approximately $417,000. Finally, Wingate Wealth Advisors Inc. purchased a new position in shares of Henry Schein during the 4th quarter worth approximately $176,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the business's stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company's stock, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.14% of the stock is currently owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.